Health outcomes variables important to patients in the treatment of erectile dysfunction

被引:106
|
作者
Hanson-Divers, C [1 ]
Jackson, SE
Lue, TF
Crawford, SY
Rosen, RC
机构
[1] Managed Care Resources, Dept Pharmacotherapy Outcomes Res, Chesapeake, VA USA
[2] Pfizer Inc, Outcomes Res, New York, NY USA
[3] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA
[4] Univ Illinois, Coll Pharm, Dept Pharm Adm, Chicago, IL USA
[5] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Psychiat, Piscataway, NJ 08854 USA
来源
JOURNAL OF UROLOGY | 1998年 / 159卷 / 05期
关键词
penis; impotence; outcome assessment (health care); research;
D O I
10.1097/00005392-199805000-00037
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Erectile dysfunction is underreported and the rate of noncompliance with therapy is high. The National Institutes of Health Consensus Conference on Impotence endorsed the need for outcomes research of the various approaches to treatment. The purpose of our exploratory study was to begin that process through identification of erectile dysfunction treatment outcomes variables that are important to men. Materials and Methods: The study format consisted of focus group meetings. The goal of the discussions was to identify variables that are important to men when choosing among and judging the success of treatment modalities for erectile dysfunction. After discussion participants were individually asked to identify the 10 variables that they considered important and rank the 5 most important variables. An importance score reflecting group consensus was calculated for each variable. Results: Success and negative outcomes were identified as the 2 most important outcomes variables for all treatment modalities. Participants defined success in several ways. The most important measures of success were cure, pleasure and partner satisfaction. Negative outcome was defined as negative consequences associated with treatment. Conclusions: The focus group discussion assisted in identifying and defining outcomes variables important to patients with erectile dysfunction. We believe that understanding issues and outcomes important to such patients is necessary to increase compliance with treatment and, thereby, increase the success of treatment of this widespread condition.
引用
收藏
页码:1541 / 1547
页数:7
相关论文
共 50 条
  • [31] Erectile dysfunction treatment with Uprima in Poland - Patients opinions
    Starowicz, ZL
    SEXUALITY AND DISABILITY, 2004, 22 (04) : 249 - 249
  • [32] Pharmacological treatment and inappropriate prescriptions for patients with erectile dysfunction
    Luis Fernando Valladales-Restrepo
    Jorge Enrique Machado-Alba
    International Journal of Clinical Pharmacy, 2021, 43 : 900 - 908
  • [33] Pharmacological treatment and inappropriate prescriptions for patients with erectile dysfunction
    Valladales-Restrepo, Luis Fernando
    Machado-Alba, Jorge Enrique
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (04) : 900 - 908
  • [34] COMBINED TREATMENT OF ERECTILE DYSFUNCTION IN PATIENTS WITH SECONDARY HYPOGONADISM
    Gorpynchenko, I
    Romaniuk, M.
    Gurzhenko, J.
    Imshinetskaja, L.
    Aksenov, P.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 366 - 366
  • [35] Vardenafil in patients with erectile dysfunction: Achieving treatment optimization
    Hellstrom, WJG
    Elhilali, M
    Homering, M
    Taylor, T
    Gittleman, M
    JOURNAL OF ANDROLOGY, 2005, 26 (05): : 604 - 609
  • [36] Research instruments for the diagnosis and treatment of patients with erectile dysfunction
    Rosen, Raymond C.
    Althof, Stanley E.
    Giuliano, Francois
    UROLOGY, 2006, 68 (3A) : 6 - 16
  • [37] Venous leak and erectile dysfunction - an important differential
    Kaba, Rahim
    Pearce, Ian
    JOURNAL OF CLINICAL UROLOGY, 2020, 13 (01) : 33 - 39
  • [38] Treatment program for erectile dysfunction in patients with cardiovascular diseases
    Israilov, S
    Baniel, J
    Shmueli, J
    Niv, E
    Engelstein, D
    Segenreich, E
    Livne, PM
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (06): : 689 - 693
  • [39] The prevalence, etiology, and treatment of hyperprolactinemia in patients with erectile dysfunction
    Marumo, K.
    Miyajima, A.
    Horiguchi, Y.
    Nakagawa, K.
    Oya, M.
    Ohigashi, T.
    Nakashima, J.
    Murai, M.
    JOURNAL OF SEXUAL MEDICINE, 2004, 1 : 127 - 128
  • [40] Erectile dysfunction: etiology and treatment in young and old patients
    Tariq, SH
    Haleem, U
    Omran, ML
    Kaiser, FE
    Perry, HM
    Morley, JE
    CLINICS IN GERIATRIC MEDICINE, 2003, 19 (03) : 539 - +